Shockwave Medical is clearing the way for Johnson & Johnson MedTech to retake its title as the world's largest medical device ...

The firm will continue developing Lava's two partnered bispecific gamma delta T-cell engager programs with Pfizer and Johnson & Johnson.

Shockwave Medical CMO Dr. Nick West discusses the intravascular lithotripsy developer's plans for next-gen devices and new ...

Johnson & Johnson (NYSE: JNJ) is one of the top cheap pharmaceutical stocks to buy now. On July 29, Johnson & Johnson ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Advisors XOMA Royalty was represented by Gibson, Dunn & Crutcher LLP and Loyens & Loeff N.V, who acted as U.S. and Dutch legal advisors, respectively. Leerink Partners is acting as exclusive financial ...

CVS, JNJ, and Tenet Healthcare shine as defensive picks with strong earnings momentum and attractive valuations.

Johnson & Johnson is a globally diversified healthcare conglomerate with two main operating segments. The Innovative Medicine ...

Why pharma companies' "price transparency" reports paint a murky picture of how much Americans spend on prescription drugs.

Johnson & Johnson is still facing many lawsuits that threaten its business. It may face additional challenges from patent cliffs and regulatory changes. Despite that, the drugmaker has important ...

B&G Foods stock is trading at deep-value levels with a massive 17% dividend yield. This beaten-down food company is an ...

Johnson & Johnson (JNJ) just got a fresh "Moderate Buy" consensus from the experts, and isn’t that a sweet melody to investor ...